Loading
Latest filing published 23 Dec 2025 for Genprex, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Ryan M. Confer appears in our data through filings on Genprex, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 28 July 2022 to 27 February 2026, the count stands at 8 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 27 February 2026 with a share grant (€16k) in Genprex, Inc. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations